» Articles » PMID: 38260080

Shedding Light on the Next Pandemic Path, from Outpatient to ICU, the Effect of Vitamin D Deficiency in the SARS-CoV-2 Pandemic

Overview
Journal Front Nutr
Date 2024 Jan 23
PMID 38260080
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitamin D insufficiency is named "the pandemic of our era" by some experts. World Health Organization warns against a "deadlier outbreak" than the COVID-19 pandemic. Critical evidence is hereby for future pandemic prevention, with special emphasis on Vitamin D.

Methods: A cross-sectional study was conducted with 172 unvaccinated adult participants, who presented to the emergency department. Blood measurements, radiological findings, and demographic features were evaluated in the four categories of "healthy adults, COVID-19 outpatients, hospitalized inpatients on the wards, and in the ICU."

Results: Results were statistically significant in association with age, gender, weight, Vitamin D, glucose, urea, creatinine, leucocyte, aspartate transaminase, hemoglobin, C-reactive protein, troponin, platelet/thrombocyte, ferritin, D-dimer, triglycerate, glycated haemoglobin, lactate dehydrogenase measurements, and chest computed tomography features (each < 0.050).

Conclusion: This article presents evidence to support the importance of Vitamin D for global public health. Patients with adequate levels of Vitamin D, glucose, urea, creatinine, leucocyte, aspartate transaminase, hemoglobin, C-reactive protein, troponin, platelet/thrombocyte, ferritin, D-dimer, triglycerate, glycated haemoglobin, lactate dehydrogenase are less likely to be admitted to ICU versus being outpatients. Factors include gender, age, weight, comorbidities, and computed tomography findings. The ultimate goal is to globally minimize preventable burdens of disease and death.

References
1.
Carpagnano G, Di Lecce V, Quaranta V, Zito A, Buonamico E, Capozza E . Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J Endocrinol Invest. 2020; 44(4):765-771. PMC: 7415009. DOI: 10.1007/s40618-020-01370-x. View

2.
Guner A, Surmeli A, Kural K, Yilmaz H, Kocayigit E, Sahin E . ICU admission rates in Istanbul following the addition of favipiravir to the national COVID-19 treatment protocol. North Clin Istanb. 2021; 8(2):119-123. PMC: 8039109. DOI: 10.14744/nci.2021.60420. View

3.
Karahan S, Katkat F . Impact of Serum 25(OH) Vitamin D Level on Mortality in Patients with COVID-19 in Turkey. J Nutr Health Aging. 2021; 25(2):189-196. PMC: 7533663. DOI: 10.1007/s12603-020-1479-0. View

4.
Guven M, Gultekin H . The effect of high-dose parenteral vitamin D on COVID-19-related inhospital mortality in critical COVID-19 patients during intensive care unit admission: an observational cohort study. Eur J Clin Nutr. 2021; 75(9):1383-1388. PMC: 8299443. DOI: 10.1038/s41430-021-00984-5. View

5.
Trummer C, Schwetz V, Pandis M, Grubler M, Verheyen N, Gaksch M . Effects of Vitamin D Supplementation on IGF-1 and Calcitriol: A Randomized-Controlled Trial. Nutrients. 2017; 9(6). PMC: 5490602. DOI: 10.3390/nu9060623. View